Petros Pharmaceuticals, Inc. Annual Earnings Per Share, Basic in USD/shares from 2020 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Petros Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
  • Petros Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.53 USD/shares, a 81.4% increase year-over-year.
  • Petros Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -4.23 USD/shares, a 37.2% increase year-over-year.
  • Petros Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -6.35 USD/shares, a 34.4% increase from 2022.
  • Petros Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -9.68 USD/shares, a 17.3% decline from 2021.
  • Petros Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -8.25 USD/shares, a 114% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$6 +$3.33 +34.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 -$10 -$1 -17.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$8 -$4 -114% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 -$4 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.